Amedisys, Inc. (AMED) reported adjusted earnings per share (EPS) of $1.32 in the second quarter of 2024, down 3.6% year over year. However, the metric beat the Zacks Consensus Estimate by 8.2%.The quarter’s adjustments include certain merger-related expenses and other (income)/expenses, net.GAAP EPS in the second quarter was 98 cents compared to a loss of $2.46 in the same period last year.Net service revenues totaled $591.2 million, up 6.9% year over year. The top line surpassed the Zacks Consensus Estimat ...